Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPB-31121 in Progressive Hepatocellular Carcinoma
NCT01406574Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jul 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OPB-31121 in hepatocellular carcinoma (HCC), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Jul 2011; status: completed.
02
Drugs
OPB-31121
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01406574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01406574.